1.36
Precedente Chiudi:
$1.47
Aprire:
$1.38
Volume 24 ore:
1.26M
Relative Volume:
0.12
Capitalizzazione di mercato:
$54.56M
Reddito:
-
Utile/perdita netta:
$-20.62M
Rapporto P/E:
-2.0491
EPS:
-0.6637
Flusso di cassa netto:
$-15.42M
1 W Prestazione:
-2.86%
1M Prestazione:
+2.26%
6M Prestazione:
-4.23%
1 anno Prestazione:
-32.67%
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BEAT
Heartbeam Inc
|
1.36 | 54.56M | 0 | -20.62M | -15.42M | -0.6637 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-31 | Iniziato | Roth Capital | Buy |
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
HeartBeam Earnings Call Balances Breakthroughs With Cash Risk - TipRanks
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch By Investing.com - Investing.com Australia
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam (NASDAQ: BEAT) files $100M shelf; $78.8M previously registered unsold - Stock Titan
HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - NewMediaWire
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - USA Today
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey
HeartBeam, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
Precision Neuroscience, founded by Neuralink alums, is developing a competing brain implant that it says is safer - AOL.com
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India
HeartBeam Q4 2025 Earnings Call Transcript - MarketBeat
HeartBeam, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-03-12 - Seeking Alpha
Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com
HeartBeam : Investor Presentation – March 2026 - marketscreener.com
HeartBeam : Fourth Quarter 2025 Earnings Conference Call Presentation - marketscreener.com
HeartBeam Q4 net loss widens - TradingView
BEAT: FDA-cleared at-home ECG, new partnerships, and improved cash position drive growth - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2025 Results - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences - USA Today
Panic Selling: Can HeartBeam Inc outperform in the next rally2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
HeartBeam announces first commercial customer as ClearCardio brings groundbreaking 12-lead ECG technology to high-growth preventive cardiology market - MSN
HeartBeam partners with Mount Sinai on AI-ECG development By Investing.com - Investing.com Canada
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai - Bitget
HeartBeam advances portable cardiac monitoring platform after FDA clearance - DOTmed
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study - Stocktwits
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home - Stocktwits
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Stocktwits
HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - NewMediaWire
Heartbeam Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam partners with Mount Sinai on AI-ECG development - Investing.com Nigeria
HeartBeam and Mount Sinai Announce Strategic AI Collaboration - Medical Product Outsourcing
HeartBeam Enters Commercial Market, Boosts Cardiovascular Technology Horizons - timothysykes.com
HeartBeam to present at March investor conferences By Investing.com - Investing.com Canada
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch - 01net
Aug EndMonth: Is HeartBeam Inc. a cyclical or defensive stock2026 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Market Outlook: Can HeartBeam Inc maintain its current growth rate2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why HeartBeam Inc. stock attracts high net worth investorsOil Prices & Weekly Setup with ROI Potential - Naître et grandir
Support Test: What are HeartBeam Inc Equity Warrants recent SEC filings showingSwing Trade & Weekly Chart Analysis and Guides - baoquankhu1.vn
ClearCardio, HeartBeam Team Up to Bring 12-Lead ECG Technology to Preventive Cardiology Market - Diagnostic and Interventional Cardiology
HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - NewMediaWire
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - Digital Journal
HeartBeam Enrolls 1st Patients in ALIGN-ACS Heart Attack Study - Medical Product Outsourcing
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time - ChartMill
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):